Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

963
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
963

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PulseSelect vs FARAPULSE pulsed field ablation: Comparative analysis of myocardial, neural-injury and hemolysis biomarkers and short-term outcomes.

International journal of cardiology. Heart & vasculature·2026
Same author

Interactions of blood biomolecules with early rhythm control in atrial fibrillation patients: Exploratory analysis of the EAST-AFNET 4 Biomolecule Study.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Analgosedation for catheter ablation in deep sedation: comparison between cryoballoon and pulsed field ablation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Early treatment of Atrial fibrillation for Stroke prevention Trial in acute STROKE (EAST-STROKE): protocol for an international investigator-initiated, prospective, randomised, open, blinded endpoint assessment (PROBE) interventional multi-centre trial.

European stroke journal·2026
Same author

International expert consensus on a structured approach to training for cryoballoon-based ablation for atrial fibrillation procedure using performance metrics.

European heart journal open·2026
Same author

Effectiveness and Safety of Early Rhythm Control in Patients With Atrial Fibrillation and Chronic Kidney Disease.

Journal of the American College of Cardiology·2026

Related Experiment Video

Updated: Jul 7, 2025

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.7K

Atrial Fibrillation Ablation: Current Practice and Future Perspectives.

Laura Rottner1, Andreas Metzner1

  • 1University Heart and Vascular Center, University Hospital Hamburg-Eppendorf, 20251 Hamburg, Germany.

Journal of Clinical Medicine
|December 23, 2023
PubMed
Summary

Catheter ablation for atrial fibrillation (AF) improves quality of life. Cryoballoon pulmonary vein isolation (PVI) shows promise as a first-line therapy, with new pulsed-field ablation (PFA) technologies emerging.

Keywords:
ablation technologiesatrial fibrillationcatheter ablationindicationpatient selection

More Related Videos

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.4K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.4K

Related Experiment Videos

Last Updated: Jul 7, 2025

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.7K
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.4K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.4K

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Technology

Background:

  • Catheter ablation for pulmonary vein isolation (PVI) is a primary treatment for atrial fibrillation (AF).
  • AF ablation offers symptom relief and improved quality of life, and can reduce mortality in heart failure patients.
  • Optimal management of comorbidities is crucial for reducing AF recurrence post-ablation.

Purpose of the Study:

  • To review current practices in AF ablation.
  • To discuss future perspectives in AF ablation technologies and strategies.
  • To highlight the efficacy and safety of various ablation modalities.

Main Methods:

  • Review of current literature on catheter ablation for AF.
  • Analysis of established techniques like radiofrequency (RF) and cryoballoon (CB) ablation.
  • Exploration of emerging technologies such as pulsed-field ablation (PFA).

Main Results:

  • Catheter ablation is recommended as second-line therapy for symptomatic AF refractory to medication.
  • Cryoballoon (CB) PVI demonstrates high efficiency, success rates, and safety, proving superior to pharmacological treatment as first-line therapy.
  • Pulsed-field ablation (PFA) shows promise due to its cardioselectivity, with advancements in catheter technology.

Conclusions:

  • Catheter ablation, particularly CB-PVI, is increasingly important as a first-line AF treatment.
  • PFA represents a significant advancement in ablation technology with potential for improved outcomes.
  • Multimodal risk assessment and therapy are essential for successful AF management.